HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway

Nucleic Acids Research

Volumn 42, Issue 15, 2014, Pages 9862-9879

  Xue, Min ^a,b   Yao, Shuihong ^c   Hu, Minmin ^a   Li, Wan ^a   Hao, Tingting ^a   Zhou, Feng ^a   Zhu, Xiaofei ^a   Lu, Hongmei ^d   Qin, Di ^a   Yan, Qin ^a   Zhu, Jianzhong ^e   Gao, Shou Jiang ^f   Lu, Chun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c School of Medicine   (China)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 718; NEF PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; K1 PROTEIN, HUMAN HERPESVIRUS 8; MIRN718 MICRORNA, HUMAN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHICKEN; CONTROLLED STUDY; DOWN REGULATION; ECTOPIC EXPRESSION; ENZYME REGULATION; ENZYME SYNTHESIS; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE TARGETING; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; KAPOSI SARCOMA; MALE; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE K1; ONCOGENE NEF; PRIORITY JOURNAL; PROTEIN RNA BINDING; SIGNAL TRANSDUCTION; UPREGULATION; ANGIOGENESIS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; CHICK EMBRYO; CYTOLOGY; ENDOTHELIUM CELL; ENZYMOLOGY; HUMAN; METABOLISM; NUDE MOUSE;

ANIMALS; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; CHICK EMBRYO; ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VIRAL PROTEINS;

EID: 84917691532     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku583     Document Type: Article

References (97)

1. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M. and Moore, P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266, 1865-1869.
2. Mesri, E.A., Cesarman, E. and Boshoff, C. (2010) Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer, 10, 707-719.
3. Cullen, B.R. (2011) Viruses and microRNAs: RISCy interactions with serious consequences. Genes Dev., 25, 1881-1894.
4. Wen, K.W. and Damania, B. (2010) Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett., 289, 140-150.
5. Jones, T., Ramos da Silva, S., Bedolla, R., Ye, F., Zhou, F. and Gao, S.J. (2014) Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition. Cell Cycle, 13, 845-858.
6. Moody, R., Zhu, Y., Huang, Y., Cui, X., Jones, T., Bedolla, R., Lei, X., Bai, Z. and Gao, S.J. (2013) KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog., 9, e1003857.
7. Prakash, O., Tang, Z.Y., Peng, X., Coleman, R., Gill, J., Farr, G. and Samaniego, F. (2002) Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene. J. Natl Cancer Inst., 94, 926-935.
8. Berkova, Z., Wang, S., Wise, J.F., Maeng, H., Ji, Y. and Samaniego, F. (2009) Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein. J. Natl Cancer Inst., 101, 399-411.
9. Wang, S., Maeng, H., Young, D.P., Prakash, O., Fayad, L.E., Younes, A. and Samaniego, F. (2007) K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis. Blood, 109, 2174-2182.
10. Tomlinson, C.C. and Damania, B. (2004) The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J. Virol., 78, 1918-1927.
11. Strathdee, S.A., Veugelers, P.J. and Moore, P.S. (1996) The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery. AIDS, 10(Suppl. A) S51-S57.
12. Delli Bovi, P., Donti, E., Knowles, D.M. 2nd, Friedman-Kien, A., Luciw, P.A., Dina, D., Dalla-Favera, R. and Basilico, C. (1986) Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi's sarcoma. Cancer Res., 46, 6333-6338.
13. Ensoli, B., Barillari, G. and Gallo, R.C. (1992) Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol. Rev., 127, 147-155.
14. Fiorelli, V., Gendelman, R., Samaniego, F., Markham, P.D. and Ensoli, B. (1995) Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest., 95, 1723-1734.
15. Barillari, G., Gendelman, R., Gallo, R.C. and Ensoli, B. (1993) The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl Acad. Sci. U.S.A., 90, 7941-7945.
16. Ensoli, B. and Cafaro, A. (1996) HIV-1 and Kaposi's sarcoma. Eur. J. Cancer Prev., 5, 410-412.
17. Zeng, Y., Zhang, X., Huang, Z., Cheng, L., Yao, S., Qin, D., Chen, X., Tang, Q., Lv, Z., Zhang, L. et al. (2007) Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J. Virol., 81, 2401-2417.
18. Chen, X., Cheng, L., Jia, X., Zeng, Y, Yao, S., Lv, Z., Qin, D., Fang, X., Lei, Y and Lu, C. (2009) Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice. Neoplasia, 11, 1272-1284.
19. Guo, H.G., Pati, S., Sadowska, M., Charurat, M. and Reitz, M. (2004) Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J. Virol, 78, 9336-9342.
20. Zhou, F., Xue, M., Qin, D., Zhu, X., Wang, C, Zhu, J., Hao, T, Cheng, L., Chen, X., Bai, Z. et al. (2013) HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3beta signaling pathway. PLoS One., 8, e53145.
21. Kestler, H.W. 3rd, Ringler, D.J., Mori, K, Panicali, D.L., Sehgal, PK, Daniel, M.D. and Desrosiers, R.C. (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell, 65, 651-662.
22. Raymond, A.D., Campbell-Sims, TC, Khan, M., Lang, M., Huang, M.B., Bond, VC. and Powell, M.D. (2011) HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res. Hum. Retroviruses, 27, 167-178.
23. Caby, M.P., Lankar, D., Vincendeau-Scherrer, C, Raposo, G and Bonnerot, C. (2005) Exosomal-like vesicles are present in human blood plasma. Int. Immunol, 17, 879-887.
24. Guy, B., Keny, M.P, Riviere, Y, Le Peuch, C, Dott, K, Girard, M., Montagnier, L. and Lecocq, J.P (1987) HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature, 330, 266-269.
25. Fujii, Y, Otake, K, Tashiro, M. and Adachi, A. (1996) Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett., 393, 93-96.
26. Guy, B., Riviere, Y, Dott, K, Regnault, A. and Kieny, M.P (1990) Mutational analysis of the HIV nef protein. Virology, 176, 413-425.
27. Macreadie, I.G., Fernley, R., Castelli, L.A., Lucantoni, A., White, J. and Azad, A. (1998) Expression of HIV-1 nef in yeast causes membrane perturbation and release of the myristylated Nef protein. J. Biomed. Sci., 5, 203-210.
28. Cullen, B.R. (1998) HIV-1 auxiliary proteins: making connections in a dying cell. Cell, 93, 685-692.
29. Qiao, X., He, B., Chiu, A., Knowles, D.M., Chadburn, A. and Cerutti, A. (2006) Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol, 7, 302-310.
30. Yan, Q., Ma, X., Shen, C, Cao, X., Feng, N, Qin, D., Zeng, Y, Zhu, J., Gao, S.J. and Lu, C. (2014) Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular MicroRNA hsa-miR-1258. J. Virol, 88, 4987-5000.
31. Marecki, J.C., Cool, C.D., Parr, J.E., Beckey, VE., Luciw, PA, Tarantal, A.F, Carville, A., Shannon, R.P, Cota-Gomez, A., Tuder, R.M. et al. (2006) HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am. J. Respir Crit. Care Med., 174, 437-445.
32. Zhu, X., Guo, Y, Yao, S., Yan, Q., Xue, M., Hao, T, Zhou, F, Zhu, J., Qin, D. and Lu, C. (2014) Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Oncogene, 33, 1986-1996.
33. Bellare, P and Ganem, D. (2009) Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe, 6, 570-575.
34. Lei, X., Bai, Z., Ye, F, Xie, J., Km, C.G, HuangY and Gao, S.J. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat. Cell Biol, 12, 193-199.
35. Lu, F, Stedman, W., Yousef, M., Renne, R. and Lieberman, PM. (2010) Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol, 84, 2697-2706.
36. Liang, D., Gao, Y, Lin, X., He, Z., Zhao, Q., Deng, Q. and Lan, K (2011) A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKepsilon. Cell Res., 21, 793-806.
37. Lin, X., Liang, D., He, Z., Deng, Q., Robertson, E.S. and Lan, K (2011) miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS One, 6, e16224.
38. Lu, C.C., Li, Z., Chu, C.Y, Feng, J., Feng, J., Sun, R. and Rana, TM. (2010) MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep., 11, 784-790.
39. Bai, Z., Huang Y, Li, W., Zhu, Y, Jung, J.U., Lu, C. and Gao, S.J. (2014) Genomewide mapping and screening of Kaposi's sarcoma-associated herpesvirus (KSHV) 3' untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAs. J. Virol., 88, 377-392.
40. Abend, J.R., Uldrick, T and Ziegelbauer, J.M. (2010) Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J. Virol, 84, 12 139-12 151.
41. Abend, J.R., Ramalingam, D., Kieffer-Kwon, P, Uldrick, TS., Yarchoan, R. and Ziegelbauer, J.M. (2012) Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. J. Virol., 86, 11 663-11 674.
42. Boss, I.W., Nadeau, PE, Abbott, J.R., Yang, Y, Mergia, A. and Renne, R. (2011) A Kaposi's sarcoma-associatedherpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rgammanull mice. J. Virol, 85, 9877-9886.
43. Dahlke, C, Maul, K, Christalla, T, Walz, N, Schult, P, Stocking, C. and Grundhoff, A. (2012) A microRNA encoded by Kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivo. PLoS One, 7, e49435.
44. Gottwein, E., Mukherjee, N, Sachse, C, Frenzel, C, Majoros, W.H, Chi, J.T, Braich, R., Manoharan, M., Soutschek, J., Ohler, U. et al. (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature, 450, 1096-1099.
45. Hansen, A., Henderson, S., Lagos, D., Nikitenko, L., Coulter, E., Roberts, S., Gratrix, F, Plaisance, K., Renne, R., Bower, M. et al. (2010) KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev., 24, 195-205.
46. Lei, X., Zhu, Y, Jones, T, Bai, Z., Huang Y and Gao, S.J. (2012) A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor beta pathway to promote cell survival. J. Virol, 86, 11 698-11 711.
47. Liu, Y, Sun, R., Lin, X., Liang, D., Deng, Q. and Lan, K (2012) Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. J. Virol, 86, 1372-1381.
48. Nachmani, D., Stern-Ginossar, N, Sarid, R. and Mandelboim, O. (2009) Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe, 5, 376-385.
49. Qin, Z., Freitas, E., Sullivan, R., Mohan, S., Bacelieri, R., Branch, D., Romano, M., Kearney, P, Oates, J., Plaisance, K et al. (2010) Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoSPathog, 6, e1000742.
50. Qin, Z., Kearney, P, Plaisance, K and Parsons, C.H. (2010) Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J. Leukoc. Biol, 87, 25-34.
51. Samols, M.A., Skalsky, R.L., Maldonado, A.M., Riva, A., Lopez, M.C, Baker, H.V and Renne, R. (2007) Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog, 3, e65.
52. Skalsky, R.L., Samols, M.A., Plaisance, K.B., Boss, I.W., Riva, A., Lopez, M.C, Baker, H.V and Renne, R. (2007) Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol, 81, 12 836-12 845.
53. Suffert, G, Malterer, G, Hausser, J., Viiliainen, J., Fender, A., Contrant, M., Ivacevic, T, Benes, V, Gros, F, Voinnet, O. et al. (2011) Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis. PLoS Pathog, 7, e1002405.
54. Ziegelbauer, J.M., Sullivan, C.S. and Ganem, D. (2009) Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat. Genet., 41, 130-134.
55. Kang, J.G., Majerciak, V., Uldrick, T.S., Wang, X., Kruhlak, M., Yarchoan, R. and Zheng, Z.M. (2011) Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J. Pathol., 225, 378-389.
56. Sgarbanti, M., Arguello, M., tenOever, B.R., Battistini, A., Lin, R. and Hiscott, J. (2004) A requirement for NF-kappaB induction in the production of replication-competent HHV-8 virions. Oncogene, 23, 5770-5780.
57. Poon, M., Zhang, X., Dunsky, K.G., Taubman, M.B. and Harpel, P.C. (1997) Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells. Circulation, 96, 2514-2519.
58. Zhu, X., Zhou, F., Qin, D., Zeng, Y., Lv, Z., Yao, S. and Lu, C. (2011) Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-kappaB signaling pathways. J. Mol. Biol., 410, 1035-1051.
59. Du, L., Wang, H., He, L., Zhang, J., Ni, B., Wang, X., Jin, H., Cahuzac, N., Mehrpour, M., Lu, Y. et al. (2008) CD44 is of functional importance for colorectal cancer stem cells. Clin. Cancer Res., 14, 6751-6760.
60. Aranda, E. and Owen, G.I. (2009) A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. Biol. Res., 42, 377-389.
61. Yan, Q., Li, W., Tang, Q., Yao, S., Lv, Z., Feng, N., Ma, X., Bai, Z., Zeng, Y., Qin, D. et al. (2013) Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA. PLoS One, 8, e55832.
62. Ebert, M.S., Neilson, J.R. and Sharp, P.A. (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods, 4, 721-726.
63. Wang, L., Dittmer, D.P., Tomlinson, C.C., Fakhari, F.D. and Damania, B. (2006) Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res., 66, 3658-3666.
64. Vivanco, I. and Sawyers, C.L. (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer, 2, 489-501.
65. Jenner, R.G., Alba, M.M., Boshoff, C. and Kellam, P. (2001) Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol., 75, 891-902.
66. Lagunoff, M. and Ganem, D. (1997) The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology, 236, 147-154.
67. Lee, B.S., Connole, M., Tang, Z., Harris, N.L. and Jung, J.U. (2003) Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein. J. Virol., 77, 8072-8086.
68. Wang, L., Wakisaka, N., Tomlinson, C.C., DeWire, S.M., Krall, S., Pagano, J.S. and Damania, B. (2004) The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res., 64, 2774-2781.
69. Cattelan, A.M., Calabro, M.L., Gasperini, P., Aversa, S.M., Zanchetta, M., Meneghetti, F., De Rossi, A. and Chieco-Bianchi, L. (2001) Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. J. Natl Cancer Inst. Monogr., 44-49.
70. Engels, E.A., Biggar, R.J., Marshall, V.A., Walters, M.A., Gamache, C.J., Whitby, D. and Goedert, J.J. (2003) Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS, 17, 1847-1851.
71. Guadalupe, M., Pollock, B.H., Westbrook, S., Redding, S., Bullock, D., Anstead, G., Agan, B.K., Marconi, V.C., Barbieri, S., Sankar, V. et al. (2011) Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy. J. Acquir. Immune Defic. Syndr., 56, 83-90.
72. Ye, F., Lei, X. and Gao, S.J. (2011) Mechanisms of Kaposi's sarcoma-associated herpesvirus latency and reactivation. Adv. Virol., 2011, 193860.
73. Lempiainen, H. and Halazonetis, T.D. (2009) Emerging common themes in regulation of PIKKs and PI3Ks. EMBO J., 28, 3067-3073.
74. Montaner, S. (2007) Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Cell Cycle, 6, 438-443.
75. Morris, V.A., Punjabi, A.S. and Lagunoff, M. (2008) Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells. J. Virol., 82, 8771-8779.
76. Engelman, J.A. (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer, 9, 550-562.
77. Jiang, B.H. and Liu, L.Z. (2009) PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv. Cancer Res., 102, 19-65.
78. Bueno, M.J., Perez de Castro, I. and Malumbres, M. (2008) Control of cell proliferation pathways by microRNAs. Cell Cycle, 7, 3143-3148.
79. Wolf, D., Witte, V., Laffert, B., Blume, K., Stromer, E., Trapp, S., d'Aloja, P., Schurmann, A. and Baur, A.S. (2001) HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat. Med., 7, 1217-1224.
80. Cheney, L., Hou, J.C., Morrison, S., Pessin, J. and Steigbigel, R.T. (2011) Nef inhibits glucose uptake in adipocytes and contributes to insulin resistance in human immunodeficiency virus type I infection. J. Infect. Dis., 203, 1824-1831.
81. Tachado, S.D., Li, X., Swan, K., Patel, N. and Koziel, H. (2008) Constitutive activation of phosphatidylinositol 3-kinase signaling pathway down-regulates TLR4-mediated tumor necrosis factor-alpha release in alveolar macrophages from asymptomatic HIV-positive persons in vitro. J. Biol. Chem., 283, 33 191-33 198.
82. Liu, X., Shah, A., Gangwani, M.R., Silverstein, P.S., Fu, M. and Kumar, A. (2014) HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors. Sci. Rep., 4, 4450.
83. Raisch, J., Darfeuille-Michaud, A. and Nguyen, H.T. (2013) Role of microRNAs in the immune system, inflammation and cancer. World J. Gastroenterol., 19, 2985-2996.
84. Yang, H., Kong, W., He, L., Zhao, J.J., O'Donnell, J.D., Wang, J., Wenham, R.M., Coppola, D., Kruk, P.A., Nicosia, S.V. et al. (2008) MicroRNA expression profling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res., 68, 425-433.
85. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S.T. and Patel, T. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658.
86. Xiao, C., Srinivasan, L., Calado, D.P., Patterson, H.C., Zhang, B., Wang, J., Henderson, J.M., Kutok, J.L. and Rajewsky, K. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol., 9, 405-414.
87. Pezzolesi, M.G., Platzer, P., Waite, K.A. and Eng, C. (2008) Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. Am. J. Hum. Genet., 82, 1141-1149.
88. Iliopoulos, D., Jaeger, S.A., Hirsch, H.A., Bulyk, M.L. and Struhl, K. (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell, 39, 493-506.
89. Tumaneng, K., Schlegelmilch, K., Russell, R.C., Yimlamai, D., Basnet, H., Mahadevan, N., Fitamant, J., Bardeesy, N., Camargo, F.D. and Guan, K.L. (2012) YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat. Cell Biol., 14, 1322-1329.
90. Huse, J.T., Brennan, C., Hambardzumyan, D., Wee, B., Pena, J., Rouhanifard, S.H., Sohn-Lee, C., le Sage, C., Agami, R., Tuschl, T. et al. (2009) The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev., 23, 1327-1337.
91. Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I. et al. (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol., 11, 881-889.
92. Small, E.M., O'Rourke, J.R., Moresi, V., Sutherland, L.B., McAnally, J., Gerard, R.D., Richardson, J.A. and Olson, E.N. (2010) Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc. Natl Acad. Sci. U.S.A., 107, 4218-4223.
93. Li, Y., Gao, L., Luo, X., Wang, L., Gao, X., Wang, W., Sun, J., Dou, L., Li, J., Xu, C. et al. (2013) Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood, 121, 499-509.
94. Palumbo, T., Faucz, F.R., Azevedo, M., Xekouki, P., Iliopoulos, D. and Stratakis, C.A. (2013) Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway. Oncogene, 32, 1651-1659.
95. Fornari, F., Milazzo, M., Chieco, P., Negrini, M., Marasco, E., Capranico, G., Mantovani, V., Marinello, J., Sabbioni, S., Callegari, E. et al. (2012) In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J. Pathol., 227, 275-285.
96. Lagos, D., Pollara, G., Henderson, S., Gratrix, F., Fabani, M., Milne, R.S., Gotch, F. and Boshoff, C. (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell Biol., 12, 513-519.
97. Schrauder, M.G., Strick, R., Schulz-Wendtland, R., Strissel, P.L., Kahmann, L., Loehberg, C.R., Lux, M.P., Jud, S.M., Hartmann, A., Hein, A. et al. (2012) Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One, 7, e29770.